Healthcare provider profile · identity verified

Kash Kendall Biddle, DO

Allopathic & Osteopathic Physicians|General Practice · BROKEN ARROW, OK · NPI 1073566659

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Kash Kendall Biddle, DO received $80.43 in general payments during 2025 across 4 reported records.

Dexcom, Inc. accounted for 30.5% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 5 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$80.43

4 reported records · 4 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Dexcom, Inc.	Unresolved — no canonical attribution shown	$24.56	30.5%	1	2025
Abbott Laboratories	Unresolved — no canonical attribution shown	$22.73	28.3%	1	2025
Vanda Pharmaceuticals Inc.	Unresolved — no canonical attribution shown	$17.76	22.1%	1	2025
Amgen Inc.	Unresolved — no canonical attribution shown	$15.38	19.1%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$80.43	4

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Dexcom G6 Transmitter Normalized: dexcom g6 transmitter	Medical Supply	Dexcom, Inc.	$24.56	1	2025
Source payment records 2025-04-29 · Dexcom, Inc. · $24.56 · Open Payments source
FREESTYLE LIBRE 3 Normalized: freestyle libre 3	Device	Abbott Laboratories	$22.73	1	2025
Source payment records 2025-04-29 · Abbott Laboratories · $22.73 · Open Payments source
FANAPT Normalized: fanapt	Drug	Vanda Pharmaceuticals Inc.	$17.76	1	2025
Source payment records 2025-02-26 · Vanda Pharmaceuticals Inc. · $17.76 · Open Payments source
OTEZLA Normalized: otezla	Drug	Amgen Inc.	$15.38	1	2025
Source payment records 2025-02-26 · Amgen Inc. · $15.38 · Open Payments source
REPATHA Normalized: repatha	Biological	Amgen Inc.	$15.38	1	2025
Source payment records 2025-02-26 · Amgen Inc. · $15.38 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	577	110
Omeprazole	Omeprazole	557	111
Lisinopril	Lisinopril	527	128
Amlodipine Besylate	Amlodipine Besylate	472	100
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	428	62
Meloxicam	Meloxicam	372	82
Atorvastatin Calcium	Atorvastatin Calcium	332	72
Gabapentin	Gabapentin	296	63
Pravastatin Sodium	Pravastatin Sodium	256	51
Hydrochlorothiazide	Hydrochlorothiazide	248	56
Trazodone Hcl	Trazodone Hcl	217	49
Losartan Potassium	Losartan Potassium	213	51
Metoprolol Tartrate	Metoprolol Tartrate	206	41
Fluticasone Propionate	Fluticasone Propionate	199	42
Tamsulosin Hcl	Tamsulosin Hcl	199	43
Rosuvastatin Calcium	Rosuvastatin Calcium	196	49
Furosemide	Furosemide	185	49
Metformin Hcl Er	Metformin Hcl	185	51
Albuterol Sulfate Hfa	Albuterol Sulfate	179	56
Pantoprazole Sodium	Pantoprazole Sodium	176	33
Potassium Chloride	Potassium Chloride	167	37
Montelukast Sodium	Montelukast Sodium	159	26
Metformin Hcl	Metformin Hcl	158	29
Lovastatin	Lovastatin	136	23
Fluoxetine Hcl	Fluoxetine Hcl	133	29
Oxycodone Hcl	Oxycodone Hcl	133	11
Baclofen	Baclofen	132	15
Citalopram Hbr	Citalopram Hydrobromide	130	32
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	130	42
Zolpidem Tartrate	Zolpidem Tartrate	130	20
Azithromycin	Azithromycin	118	89
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	115	16
Glimepiride	Glimepiride	115	35
Tramadol Hcl	Tramadol Hcl	108	22
Carvedilol	Carvedilol	105	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	100	23
Alprazolam	Alprazolam	99	22
Estradiol	Estradiol	90	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	90	11
Duloxetine Hcl	Duloxetine Hcl	85	17
Allopurinol	Allopurinol	84	22
Clonidine Hcl	Clonidine Hcl	82	18
Eliquis	Apixaban	78	15
Mirtazapine	Mirtazapine	77	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	76	suppressed
Ozempic	Semaglutide	76	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	75	59
Sertraline Hcl	Sertraline Hcl	72	21
Mounjaro	Tirzepatide	70	12
Metoprolol Succinate	Metoprolol Succinate	64	17
Lactulose	Lactulose	63	12
Mupirocin	Mupirocin	63	37
Quetiapine Fumarate	Quetiapine Fumarate	63	12
Alendronate Sodium	Alendronate Sodium	62	17
Tizanidine Hcl	Tizanidine Hcl	60	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	16
Clopidogrel	Clopidogrel Bisulfate	58	15
Escitalopram Oxalate	Escitalopram Oxalate	58	14
Ondansetron Hcl	Ondansetron Hcl	58	26
Fluconazole	Fluconazole	57	28
Memantine Hcl	Memantine Hcl	57	suppressed
Methylprednisolone	Methylprednisolone	57	52
Venlafaxine Hcl Er	Venlafaxine Hcl	57	suppressed
Jardiance	Empagliflozin	56	suppressed
Naproxen	Naproxen	53	suppressed
Promethazine Hcl	Promethazine Hcl	53	17
Propranolol Hcl	Propranolol Hcl	52	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	51	43
Levetiracetam	Levetiracetam	51	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	51	12
Sucralfate	Sucralfate	49	suppressed
Buspirone Hcl	Buspirone Hcl	48	suppressed
Simvastatin	Simvastatin	47	suppressed
Prednisone	Prednisone	46	23
Famotidine	Famotidine	45	suppressed
Nystop	Nystatin	44	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	44	23
Glipizide	Glipizide	43	suppressed
Ketoconazole	Ketoconazole	43	suppressed
Naltrexone Hcl	Naltrexone Hcl	43	suppressed
Diazepam	Diazepam	41	suppressed
Levofloxacin	Levofloxacin	41	32
Atenolol	Atenolol	39	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	38	12
Januvia	Sitagliptin Phosphate	38	suppressed
Ibuprofen	Ibuprofen	37	12
Cephalexin	Cephalexin	35	30
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Nystatin	Nystatin	34	20
Oxybutynin Chloride	Oxybutynin Chloride	34	suppressed
Lamotrigine	Lamotrigine	33	suppressed
Progesterone	Progesterone, Micronized	33	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	32	suppressed
Topiramate	Topiramate	32	suppressed
Benazepril Hcl	Benazepril Hcl	31	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Oxcarbazepine	Oxcarbazepine	31	suppressed
Terbinafine Hcl	Terbinafine Hcl	31	13
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	30	suppressed
Spironolactone	Spironolactone	30	12
Synthroid	Levothyroxine Sodium	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Enalapril Maleate	Enalapril Maleate	29	suppressed
Terazosin Hcl	Terazosin Hcl	29	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Finasteride	Finasteride	28	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	28	suppressed
Divalproex Sodium Er	Divalproex Sodium	27	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	22
Gemfibrozil	Gemfibrozil	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Lorazepam	Lorazepam	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Scopolamine	Scopolamine	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Vraylar	Cariprazine Hcl	23	suppressed
Megestrol Acetate	Megestrol Acetate	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	21	suppressed
Olanzapine	Olanzapine	21	suppressed
Ondansetron Odt	Ondansetron	21	13
Solifenacin Succinate	Solifenacin Succinate	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Divalproex Sodium	Divalproex Sodium	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	13
Acyclovir	Acyclovir	19	11
Amoxicillin	Amoxicillin	19	16
Carbamazepine	Carbamazepine	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	19	suppressed
Trospium Chloride	Trospium Chloride	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Nortrel	Norethindrone-Ethin. Estradiol	17	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	14
Levora-28	Levonorgestrel/Ethin.Estradiol	16	suppressed
Memantine Hcl Er	Memantine Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	11
Sulfasalazine	Sulfasalazine	16	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Amantadine	Amantadine Hcl	15	suppressed
Vascepa	Icosapent Ethyl	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Konvomep	Omeprazole/Sodium Bicarbonate	14	suppressed
Risperidone	Risperidone	14	suppressed
Torsemide	Torsemide	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Anastrozole	Anastrozole	13	suppressed
Armodafinil	Armodafinil	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Cefdinir	Cefdinir	13	suppressed
Cholestyramine Light	Cholestyramine	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Guanfacine Hcl Er	Guanfacine Hcl	13	suppressed
Linzess	Linaclotide	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Albuterol Sulfate	Albuterol Sulfate	12	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	12	suppressed
Testosterone	Testosterone	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
M-Natal Plus	Pnv,calcium 72/Iron/Folic Acid	11	suppressed
Movantik	Naloxegol Oxalate	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Rybelsus	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$80.43 · 4 records	Dexcom, Inc.	Dexcom G6 Transmitter, FANAPT, FREESTYLE LIBRE 3, OTEZLA, REPATHA	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error